Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Athersys Inc.

Start price
Target price
Perf. (%)
€1.87
19.09.22
€3.80
19.09.23
0.19%
17.10.22

Could be very worthwhile Investment >20% year
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€8.64
19.09.22
€17.00
19.09.23
-34.41%
17.10.22

Could be very worthwhile Investment >20% year
buy
Syros Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.41
27.09.22
€11.60
27.09.23
8.69%
17.10.22

Could be very worthwhile Investment >20% year
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€9.36
16.10.21
€20.00
16.10.22
47.44%
17.10.22

Could be worthwhile Investment >10% per year
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.08
18.05.22
-
18.05.23
-3.43%
16.10.22

Risky Investment
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.86
08.10.22
€5.00
08.10.23
9.28%
16.10.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€1.12
04.09.22
-
04.09.23
-11.64%
15.10.22

Could be worthwhile Investment >10% per year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€6.61
29.08.22
-
29.08.23
-10.43%
15.10.22

Could be very worthwhile Investment >20% year
buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€1.17
20.09.22
-
20.09.23
-15.38%
15.10.22

Risky Investment
buy
Galapagos N.V.

Start price
Target price
Perf. (%)
€45.08
13.10.21
€46.00
13.10.22
-0.18%
14.10.22

Could be worthwhile Investment >10% per year
buy
Galapagos N.V.

Start price
Target price
Perf. (%)
€45.08
13.10.21
€46.00
13.10.22
-0.18%
14.10.22

Could be worthwhile Investment >10% per year
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€2.91
03.08.22
€3.30
03.08.23
-12.37%
13.10.22

Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
Novavax Inc.

Start price
Target price
Perf. (%)
€34.98
27.08.22
€16.00
27.08.23
-38.94%
13.10.22

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€72.01
13.10.22
-
-
13.10.22

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€72.01
13.10.22
-
-
13.10.22

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€72.01
13.10.22
-
-
13.10.22

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€56.78
04.02.22
€46.00
04.02.23
18.67%
13.10.22

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€56.78
04.02.22
€46.00
04.02.23
18.67%
13.10.22

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€56.78
04.02.22
€46.00
04.02.23
18.67%
13.10.22

Top 10 in its market
Good rating
Medium risks for its business
Bad culture
buy
GSK plc

Start price
Target price
Perf. (%)
€20.70
20.07.22
€20.00
20.07.23
-24.56%
13.10.22

High dividend yield expected
Good rating
Very small cyclical dependencies
Fair valuation
buy
GSK plc

Start price
Target price
Perf. (%)
€20.70
20.07.22
€20.00
20.07.23
-24.56%
13.10.22

High dividend yield expected
Good rating
Very small cyclical dependencies
Fair valuation
buy
Bayer AG

Start price
Target price
Perf. (%)
€43.96
06.12.21
€48.00
12.10.22
12.32%
13.10.22

Could be worthwhile Investment >10% per year
buy
Bayer AG

Start price
Target price
Perf. (%)
€43.96
06.12.21
€48.00
12.10.22
12.32%
13.10.22

Could be worthwhile Investment >10% per year
buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€17.10
10.10.21
€15.00
10.10.22
-84.33%
11.10.22

Could be worthwhile Investment >10% per year
Some uniques
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€14.42
03.10.22
-
03.10.23
-81.66%
07.10.22

Risky Investment